|
Phenotype Submission - Glioblastoma multiforme
|
|
1
|
147
|
September 16, 2023
|
|
Phenotype Submission - Non-small cell lung cancer
|
|
1
|
257
|
September 16, 2023
|
|
Phenotype Submission - Skin Burns
|
|
1
|
190
|
September 16, 2023
|
|
Phenotype Submission - Cystic Fibrosis
|
|
1
|
184
|
September 16, 2023
|
|
Phenotype Submission - CTEPH Procedures
|
|
1
|
136
|
September 16, 2023
|
|
Phenotype Submission - Chronic Thromboembolic Pulmonary Hypertension (WHO Group 4)
|
|
2
|
215
|
September 16, 2023
|
|
Phenotype Submission - Antiphospholipid syndrome
|
|
1
|
136
|
September 16, 2023
|
|
Phenotype Submission - Raynaud’s disease or Raynaud's phenomenon
|
|
1
|
136
|
September 16, 2023
|
|
Phenotype Submission - Overlap syndrome
|
|
1
|
174
|
September 16, 2023
|
|
Phenotype Submission - Undifferentiated connective tissue disease
|
|
1
|
146
|
September 16, 2023
|
|
Phenotype Submission - Mixed connective tissue disease
|
|
1
|
147
|
September 16, 2023
|
|
Phenotype Submission - Antisynthetase syndrome
|
|
1
|
160
|
September 16, 2023
|
|
Phenotype Submission - Inflammatory Bowel Disease
|
|
3
|
163
|
September 16, 2023
|
|
Phenotype Submission - Portal Hypertension
|
|
1
|
139
|
September 16, 2023
|
|
Phenotype Submission - Congenital Heart Disease
|
|
1
|
130
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with lung diseases and/or hypoxia (WHO Group 3)
|
|
2
|
186
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with left heart disease (WHO Group 2)
|
|
2
|
408
|
September 16, 2023
|
|
Phenotype Submission - Scleroderma
|
|
1
|
138
|
September 16, 2023
|
|
Phenotype Submission - Sickle Cell Anemia
|
|
1
|
140
|
September 16, 2023
|
|
Phenotype Submission - Sarcoidosis
|
|
1
|
171
|
September 16, 2023
|
|
Phenotype Submission - Right Heart Failure
|
|
1
|
181
|
September 16, 2023
|
|
Phenotype Submission - PAH Drug Treatment Groups
|
|
1
|
159
|
September 16, 2023
|
|
Phenotype Submission - PAH plus Left Heart Disease
|
|
1
|
118
|
September 16, 2023
|
|
Phenotype Submissions - HowOften - Dual biologic therapy for IBD, PsO, and PsA
|
|
1
|
138
|
September 16, 2023
|
|
Phenotype Submission - Non-infectious uveitis and iridocyclitis
|
|
1
|
182
|
September 15, 2023
|
|
Phenotype Submission - Down Syndrome
|
|
1
|
165
|
September 15, 2023
|
|
Phenotype Submission - Motor Vehicle Accidents (MVA)
|
|
1
|
242
|
September 15, 2023
|
|
Phenotype Submission - Pulmonary Arterial Hypertension (WHO Group 1)
|
|
1
|
187
|
September 14, 2023
|
|
Phenotype Submission - Pulmonary Hypertension
|
|
1
|
177
|
September 14, 2023
|
|
Phenotype submission - Diabetic ketoacidosis
|
|
1
|
180
|
September 8, 2023
|